Clinical TrialCompleted

Evaluation of Instruments and Procedures Used to Measure Opioid Withdrawal in Opioid Dependent Participants Who are Seeking to Discontinue Methadone Opioid Substitution Treatment (OST); Evaluation of Instruments and Procedures Used to Measure Opioid Withdrawal in Opioid Dependent Participants Who are Seeking to Discontinue Methadone Opioid Substitution Treatment (OST)

This clinical trial (n=6) evaluated the safety and efficacy of the intervention for opioid dependency.

Target Enrollment
6 participants
Study Type
observational
Design
Non-randomized

Detailed Description

The objective of this study is to evaluate the instruments and procedures to be used in a subsequent study of the
safety and tolerability of noribogaine in opioid dependent Participants. In particular, this study will evaluate the
ability of various assessment scales to detect the signs and symptoms of opioid withdrawal in the study
population.

Study Arms & Interventions

Experimental Arm

experimental

Participants

Inclusion Criteria

  • The main inclusion criteria are opioid dependent male and female adults (18-55 years) who provide written consent and are on stable doses of methadone through the OST programme. Participants cannot have any other major illnesses or disorders and must be willing to comply with the restrictions of the study.

Exclusion Criteria

  • Exclusion criteria include current treatment for hepatitis C; HIV positive; DSM IV Axis I diagnosis of psychotic disorders; specified excluded concomitant medications; DSM IV criteria for dependence on substances other than opioids, caffeine, and/or nicotine.

Study Details

  • Status
    Completed
  • Type
    observational
  • Design
    Non-randomized
  • Target Enrollment6 participants
  • Timeline
    Start: 2013-07-30
    End: 2013-08-09

Locations

Unknown facility — Australia

Your Library